BioBridgeXAll companies

Window Therapeutics, Inc.

Biotechnology company · Boston, Massachusetts, United States

Window Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $299,999 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $7.5 million sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Window Therapeutics at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2021
Employees (self-reported, 2023)5
SEC CIK1997408

What does Window Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $299,999 in total (2023). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $7.5 million sold (2023).

Frequently asked questions about Window Therapeutics

Where is Window Therapeutics headquartered?

Window Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

What does Window Therapeutics do?

Window Therapeutics, Inc. is a biotechnology company.

When was Window Therapeutics founded?

The earliest incorporation on record for Window Therapeutics, Inc. is in 2021, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences